Cited 987 times in
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.